12.5/1000 322M (Kazano 12.5 mg / 1000 mg)
Generic Name: alogliptin/metformin
Pill with imprint 12.5/1000 322M is Yellow, Elliptical / Oval and has been identified as Kazano 12.5 mg / 1000 mg. It is supplied by Takeda Pharmaceuticals America, Inc..
Kazano is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kazano 12.5 mg / 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 12.5/1000 322M
Kazano
- Generic Name
- alogliptin/metformin
- Imprint
- 12.5/1000 322M
- Strength
- 12.5 mg / 1000 mg
- Color
- Yellow
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 64764-0337 | Takeda Pharmaceuticals U.S.A., Inc. |
| 45802-0211 | Perrigo Company |
Related Images for "12.5/1000 322M"
More about Kazano (alogliptin / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (4)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.